Compare FUNC & ARCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | FUNC | ARCT |
|---|---|---|
| Founded | 1900 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 251.6M | 217.9M |
| IPO Year | 2012 | 2019 |
| Metric | FUNC | ARCT |
|---|---|---|
| Price | $35.60 | $8.37 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 11 |
| Target Price | N/A | ★ $38.44 |
| AVG Volume (30 Days) | 7.9K | ★ 397.4K |
| Earning Date | 05-06-2026 | 01-01-0001 |
| Dividend Yield | ★ 2.90% | N/A |
| EPS Growth | ★ 40.00 | N/A |
| EPS | ★ 2.88 | N/A |
| Revenue | $17,715,000.00 | ★ $152,310,000.00 |
| Revenue This Year | $16.22 | N/A |
| Revenue Next Year | $8.75 | N/A |
| P/E Ratio | $12.44 | ★ N/A |
| Revenue Growth | ★ 6.27 | N/A |
| 52 Week Low | $24.80 | $5.85 |
| 52 Week High | $41.95 | $24.14 |
| Indicator | FUNC | ARCT |
|---|---|---|
| Relative Strength Index (RSI) | 39.95 | 66.62 |
| Support Level | $35.93 | $5.93 |
| Resistance Level | $36.17 | $13.78 |
| Average True Range (ATR) | 0.81 | 0.47 |
| MACD | -0.28 | 0.09 |
| Stochastic Oscillator | 19.51 | 87.27 |
First United Corp is active in the financial services domain. The scope of its offering includes checking, savings, money market deposit accounts and certificates of deposit, business loans, personal loans, mortgage loans and lines of credit extended to both individuals and businesses. The bank also provides residential real estate construction loans to builders and individuals for single-family dwellings. The company's reportable operating segments include community banking and wealth management. The company generates the majority of its revenue from the Community Banking segment, which is engaged in delivering financial products and services, including various loan and deposit products, to consumer, business, and not-for-profit customers.
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on the development of infectious disease vaccines and opportunities within liver and respiratory rare diseases. It operates in one business segment, which includes all activities related to the discovery, development, and commercialization of messenger RNA medicines. The company's pipeline includes LUNAR-OTC and LUNAR-CF. Its Vaccine candidates include LUNAR-FLU, KOSTAIVE XBB.1.5, KOSTAIVE, and Others.